ClinicalTrials.Veeva

Menu

Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation

L

LDR Medical

Status

Terminated

Conditions

Degenerative Disc Disease

Treatments

Device: Avenue® L Interbody Fusion System (LDR Spine)

Study type

Observational

Funder types

Industry

Identifiers

NCT02068768
AveL100

Details and patient eligibility

About

The purpose of this prospective clinical study is to examine the short-term safety and efficacy of the Avenue®- L interbody Spinal Fusion System with VerteBRIDGE® plating to treat one and two level degenerative disc disease between L2 and S1 with a focus on fusion rate.

Enrollment

13 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects must be candidates for on-label use of the Avenue L device (have degenerative disc disease, use only at one or two contiguous levels, posterior fixation must be used, autograft must be used in the interbody cage)
  • Subject must be skeletally mature at the time of surgery, i.e. the subject must be at least 21 years of age at the time of surgery
  • Subject should have had a minimum of 6 months of non-operative treatment prior to surgery
  • The placement of the Avenue L device must be a primary surgery
  • Subject must be willing to sign the consent form and be able to return for all follow up visits.

Exclusion criteria

  • Subject must not have had prior surgery at the operative level(s)
  • Subject is known to have substance or alcohol addictions
  • Subject has lateral curvature of the spine (scoliosis, all types)
  • Subject is a prisoner
  • Subject is pregnant
  • Subject has an active infection or sepsis at the time of surgery
  • Subject has any neuromuscular disorder that would preclude accurate neurologic evaluations

Trial design

13 participants in 1 patient group

Operated Subjects
Description:
Subjects scheduled to receive an Avenue® L Interbody Fusion System (LDR Spine) for fusion of the lumbar spine from L2-S1
Treatment:
Device: Avenue® L Interbody Fusion System (LDR Spine)

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems